Stocks retreat on Johnson & Johnson results, Goldman downgrade


A mixed earnings report from Johnson & Johnson (JNJ) and a key analyst downgrade left stocks mostly lower Tuesday.

J&J, a component of the Dow Jones Industrial Average ($INDU), said third-quarter sales fell five percent, more than Wall Street had feared. The results created concern among investors that much needed corporate revenue growth could be more anemic this reporting season than previously thought.